CytomX Therapeutics Ownership | Who Owns CytomX Therapeutics?
CytomX Therapeutics Ownership Summary
CytomX Therapeutics is owned by 153.01% institutional investors, 0.79% insiders. Vr adviser is the largest institutional shareholder, holding 16.03% of CTMX shares. Fidelity Advisor Biotechnology I is the top mutual fund, with 4.27% of its assets in CytomX Therapeutics shares.
CTMX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CytomX Therapeutics | 153.01% | 0.79% | -53.80% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vr adviser | 13.97M | 16.03% | $31.71M |
| Tang capital management | 11.07M | 12.70% | $25.12M |
| Orbimed advisors | 8.46M | 9.71% | $19.21M |
| Point72 asset management | 8.08M | 9.28% | $18.35M |
| Perceptive advisors | 6.99M | 8.03% | $15.88M |
| Vivo capital | 5.77M | 6.62% | $13.10M |
| Vanguard group | 5.16M | 6.07% | $5.32M |
| Fairmount funds management | 3.90M | 4.47% | $8.85M |
| Prosight management, lp | 3.52M | 4.04% | $7.98M |
| Baker bros. advisors lp | 3.48M | 4.00% | $7.91M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vr adviser | 13.97M | 2.38% | $31.71M |
| Prosight management, lp | 3.52M | 1.95% | $7.98M |
| Vivo capital | 5.77M | 1.34% | $13.10M |
| Tang capital management | 11.07M | 1.27% | $25.12M |
| Fairmount funds management | 3.90M | 1.15% | $8.85M |
| Adar1 capital management | 3.08M | 1.07% | $6.99M |
| Perceptive advisors | 6.99M | 0.59% | $15.88M |
| Kynam capital management, lp | 2.15M | 0.53% | $4.89M |
| Orbimed advisors | 8.46M | 0.48% | $19.21M |
| Soleus capital management | 1.30M | 0.20% | $2.96M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vr adviser | 13.97M | 2.38% | 13.97M |
| Orbimed advisors | 8.46M | 0.48% | 8.46M |
| Perceptive advisors | 6.99M | 0.59% | 6.99M |
| Vivo capital | 5.77M | 1.34% | 5.77M |
| Point72 asset management | 8.08M | 0.04% | 5.43M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | - | - | -5.23M |
| Janus henderson group | - | - | -4.81M |
| Adage capital partners gp | - | - | -3.00M |
| Acadian asset management | 1.56M | 0.01% | -1.68M |
| Sio capital management | - | - | -1.60M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vr adviser | 13.97M | 2.38% | 13.97M | $31.71M |
| Orbimed advisors | 8.46M | 0.48% | 8.46M | $19.21M |
| Perceptive advisors | 6.99M | 0.59% | 6.99M | $15.88M |
| Vivo capital | 5.77M | 1.34% | 5.77M | $13.10M |
| Fairmount funds management | 3.90M | 1.15% | 3.90M | $8.85M |
Sold Out
| Holder | Change |
|---|---|
| Innealta capital | -2.00 |
| Federated hermes | -117.00 |
| Old point trust & financial services n a | -250.00 |
| Raleigh capital management | -250.00 |
| Bell investment advisors | -388.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 88 | 35.38% | 133,304,249 | 195.10% | 153 | 5.69% | 57 | 128.00% | 16 | -36.00% |
| Mar 31, 2025 | 66 | -7.04% | 45,273,213 | -3.09% | 51 | 1.72% | 26 | -25.71% | 25 | 19.05% |
| Dec 31, 2024 | 70 | -2.78% | 46,332,988 | -9.49% | 54 | 1.50% | 34 | 21.43% | 21 | -12.50% |
| Sep 30, 2024 | 70 | -9.09% | 50,859,222 | 0.34% | 59 | 1.57% | 27 | -35.71% | 23 | - |
| Jun 30, 2024 | 77 | -15.38% | 50,687,257 | 14.42% | 61 | 1.72% | 42 | -8.70% | 23 | -8.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Advisor Biotechnology I | 3.44M | 4.27% | - |
| Fidelity Stock Selector Small Cap | 2.72M | 3.37% | 2.72M |
| Vanguard US Total Market Shares ETF | 2.46M | 3.07% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.95M | 3.00% | -109.73K |
| Fidelity Series Small Cap Opps | 2.39M | 2.97% | 2.39M |
| Franklin Biotechnology Discv A(acc)USD | 2.92M | 1.77% | -800.28K |
| Fidelity Extended Market Index | 850.89K | 1.06% | 407.89K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.71M | 1.04% | -749.87K |
| Vanguard Explorer Inv | 820.46K | 1.02% | - |
| Franklin Biotechnology Discovery A | 1.57M | 0.95% | -470.89K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | Sell | $4.84K |
| Jun 16, 2025 | Ogden Christopher | Chief Financial Officer | Sell | $28.54K |
| Jun 16, 2025 | BELVIN MARCIA | SVP, Chief Scientific Officer | Sell | $37.33K |
| Jun 16, 2025 | McCarthy Sean A. | CEO | Sell | $149.26K |
| Mar 18, 2025 | McCarthy Sean A. | CEO | Sell | $22.56K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 5 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 5 |
CTMX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools